NEWS
2024.05.07
Release
ExaWizards AI Generates Meeting Records from Audio for the Yamaguchi Financial Group
Supporting Productivity Improvements at Yamaguchi Bank, Kitakyushu Bank, And Momiji Bank by Combining Generative AI with Proprietary AI
2024.05.07
Release
ExaWizards Group to Develop Generative AI Services for Tokyo Metropolitan Schools
– Building a Unique Operating Environment Using “exaBase Generative AI,” Implemented for Educational Practices and School Affairs at 19 Schools –
2024.04.18
Release
FamilyMart Adopts “exaBase Generative AI”, Significantly Reduces Related Work Hours by Up to 50%
– Exa Enterprise AI Supports Prompt Improvement and Templatization, Encouraging Adoption and Outcome Creation –
2024.04.16
Release
“exaBase Generative AI” Supports Multiple LLMs and Patent Technology to Optimize The Use of Switching between LLMs
– Plans to Support “Claude” , “Gemini” by Google, “tsuzumi” by NTT
Expanding the Application Fields and Uses of Generative AI by Utilizing Multiple LLMs –
2024.04.15
Release
“exaBase IR Assistant” and “WizLabo” Integrated Business Reporting System Launch an API Linkage
– Streamlining Q&A Preparation for Financial Results Briefings and General Shareholder Meetings –
2024.04.11
Release
exaBase Generative AI Now Supports High-Speed GPT-4 Turbo
– Earliest Availability for using Microsoft Azure East Japan domestically through a collaboration with Microsoft Japan
High-speed response and stable operations with PTU –
2024.04.10
Release
ExaWizards Launches “exaBase Role Playing” to Enhance The Sales Capabilities of Organizations
– A New Service to Train Salespeople Anytime, Anywhere Easy Design and Feedback for Finance, Insurance, Real Estate, and other Sales Conversation Scenarios
2024.03.26
Release
Nagoya Railroad Adopts “exaBase IR Assistant”
– Using Business-Specific Generative AI, The Company will Promote IR Tech in the Disclosure-Related Divisions –
2024.03.18
Release
ExaWizards and Daiichi Sankyo Achieve Results in AI Drug Discovery, Joint Project Identified Hit Compounds on Challenging Target Proteins in a Short Period of Time
– Created an Efficient Workflow that Combined AI Technology and Structure-Based Drug Discovery, Compound Selection In 2 Months for Ultra-Large-Scale Screening –
2024.03.13
Release